In this episode of the "Heartbeat Podcast," we delve into groundbreaking research published in the New England Journal of Medicine on the efficacy of Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, for patients with heart failure and mildly reduced or preserved ejection fraction. Discover how this therapy reduces the risk of worsening heart failure events and cardiovascular mortality, and explore its implications for clinical practice.
Join us for an in-depth discussion tailored for healthcare professionals and cardiologists seeking the latest advancements in cardiac care.
Podden och tillhörande omslagsbild på den här sidan tillhör
Mohammed Al-Qadami. Innehållet i podden är skapat av Mohammed Al-Qadami och inte av,
eller tillsammans med, Poddtoppen.
